Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Ask a Clinician: What Do I Need to Know About DME Trends?

Healthesystems clinicians tackle questions about Durable Medical Equipment (DME) trends
Winter 2023/2024

State of States

A roundup of regulatory activity around the country
Winter 2023/2024

Risky Business: Evolving Risks Across Workers’ Comp

A message from the Chief Executive Officer
Summer 2023

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Recalls and Alerts Impacting Workers’ Comp

The FDA issued notices for certain migraine, acetaminophen, clonazepam, and semaglutide products.
Aug 2024

Weighing the Options: Keeping Track of New Obesity Drugs

Comorbid obesity can complicate recovery, and new drugs create new pharmacy considerations.
Aug 2024

Worker Heat Protections Continue to Make Waves

The U.S. Department of Labor proposed new rules, while other states introduce legislation.
Aug 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

IQVIA Reports on Trends and Future Outlook for Drug Utilization and Spend

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.
May 2022

CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.
Jan 2022

Can Virtual Reality Help with Pain Management?

A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.
Dec 2021
1 5 6 7 8 9 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle